{"altmetric_id":1262288,"counts":{"readers":{"mendeley":84,"citeulike":1,"connotea":0},"facebook":{"unique_users_count":2,"unique_users":["138343829568207","215693965130780"],"posts_count":2},"total":{"posts_count":8},"twitter":{"unique_users_count":4,"unique_users":["MDAMelanomaOnc","mtmdphd","mkgraziani","LungCaNetwork"],"posts_count":6}},"selected_quotes":["Oncogene (IKBKE) Links Tobacco to NSCLC #LungCancer. Guo et al. Oncogene: HT \u200f@Biotech_Updates"],"citation":{"abstract":"The treatment of melanoma, the most aggressive form of skin cancer, is being revolutionized by the development of personalized targeted therapy approaches. Mutant-selective BRAF inhibitors and MEK inhibitors have demonstrated impressive clinical results in molecularly selected patients. However, emerging understanding of the molecular heterogeneity of this disease and the identification of multiple mechanisms of resistance to targeted therapies strongly support the rationale for combinatorial approaches. In this review, we will discuss the preclinical and clinical studies that are testing leading hypotheses and emerging combinatorial strategies for the future.","abstract_source":"pubmed","altmetric_jid":"4f6fa5113cf058f610003240","authors":["Kwong LN","Davies MA","L N Kwong","M A Davies"],"doi":"10.1038\/onc.2013.34","endpage":"9","first_seen_on":"2013-02-25T15:52:41+00:00","funders":["nci"],"issns":["0950-9232","1476-5594"],"issue":"1","journal":"Oncogene","last_mentioned_on":1362058551,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23416974"],"pmid":"23416974","pubdate":"2013-02-20T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"},{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"1","subjects":["molecularbiology","neoplasms"],"title":"Targeted therapy for melanoma: rational combinatorial approaches.","type":"article","uri":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2013.34","volume":"33","mendeley_url":"http:\/\/www.mendeley.com\/research\/targeted-therapy-melanoma-rational-combinatorial-approaches"},"altmetric_score":{"score":2.6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.6},"context_for_score":{"all":{"total_number_of_other_articles":4507144,"mean":5.1294364809111,"rank":1637583,"this_scored_higher_than_pct":63,"this_scored_higher_than":2856114,"rank_type":"exact","sample_size":4507144,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":89357,"mean":6.3804321813869,"rank":26892,"this_scored_higher_than_pct":69,"this_scored_higher_than":62087,"rank_type":"exact","sample_size":89357,"percentile":69},"this_journal":{"total_number_of_other_articles":3688,"mean":2.6106829400597,"rank":1736,"this_scored_higher_than_pct":52,"this_scored_higher_than":1947,"rank_type":"exact","sample_size":3688,"percentile":52},"similar_age_this_journal_3m":{"total_number_of_other_articles":90,"mean":2.8800224719101,"rank":24,"this_scored_higher_than_pct":73,"this_scored_higher_than":66,"rank_type":"exact","sample_size":90,"percentile":73}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Scientists":1,"Members of the public":2}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":17,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":23,"Student  > Postgraduate":4,"Student  > Master":8,"Other":2,"Student  > Bachelor":4,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":24,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":35,"Biochemistry, Genetics and Molecular Biology":4}}},"geo":{"twitter":{"US":3},"mendeley":{"EC":2,"KR":1,"US":4,"ZA":2,"ES":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/MDAMelanomaOnc\/statuses\/306069155805794304","license":"public","citation_ids":[1262288],"posted_on":"2013-02-25T15:52:27+00:00","author":{"name":"Melanoma Medical Onc","url":"http:\/\/bit.ly\/YJqC93","image":"https:\/\/pbs.twimg.com\/profile_images\/876835879158927360\/64tmhrsw_normal.jpg","description":"Melanoma news from the Melanoma Medical Oncology Department at world-renowned MD Anderson Cancer Center; phone 877-632-6789","id_on_source":"MDAMelanomaOnc","tweeter_id":"281225020","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":3132},"tweet_id":"306069155805794304"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/306074054035660800","license":"public","rt":["MDAMelanomaOnc"],"citation_ids":[1262288],"posted_on":"2013-02-25T16:11:55+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"306074054035660800"},{"url":"http:\/\/twitter.com\/mkgraziani\/statuses\/306082854998274048","license":"public","rt":["mtmdphd"],"citation_ids":[1262288],"posted_on":"2013-02-25T16:46:54+00:00","author":{"name":"Mike Graziani","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000151410566\/d6589096817d0bc05c3e5e35274a1202_normal.jpeg","description":"Work:health care communications, hem\/onc clinical info & education. Personal: husband, dad, tennis player, music fan (all genres), self-taught guitarist","id_on_source":"mkgraziani","tweeter_id":"27347556","geo":{"lt":39.95234,"ln":-75.16379,"country":"US"},"followers":92},"tweet_id":"306082854998274048"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/306076881780879360","license":"public","citation_ids":[1248872,1262288],"posted_on":"2013-02-25T16:23:09+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"306076881780879360"},{"url":"http:\/\/twitter.com\/LungCaNetwork\/statuses\/306076879750848512","license":"public","citation_ids":[1248872,1262288],"posted_on":"2013-02-25T16:23:09+00:00","author":{"name":"CRAB Clinical Trials","url":"http:\/\/www.crabctc.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/550375924865064961\/9iGmcgEA_normal.png","description":"CRAB CTC aims to provide an international network to rapidly translate novel agents into new treatments for lung cancer.","id_on_source":"LungCaNetwork","tweeter_id":"361490128","geo":{"lt":null,"ln":null},"followers":454},"tweet_id":"306076879750848512"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/306075267229687808","license":"public","citation_ids":[1262288],"posted_on":"2013-02-25T16:16:44+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"306075267229687808"}],"facebook":[{"title":"Targeted therapy for melanoma: rational combinatori... [Oncogene. 2013] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=166038993546183&id=138343829568207","citation_ids":[1262288],"posted_on":"2013-02-25T15:52:19+00:00","summary":"MDAnderson Melanoma Dr M Davies & coauthor explore combined targeted therapy approaches for melanoma:Oncogene http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23416974","author":{"name":"Melanoma Medical Oncology at MD Anderson","url":"https:\/\/www.facebook.com\/138343829568207","facebook_wall_name":"Melanoma Medical Oncology at MD Anderson","image":"https:\/\/graph.facebook.com\/138343829568207\/picture","id_on_source":"138343829568207"}},{"title":"Targeted therapy for melanoma: rational combinatori... [Oncogene. 2013] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=540695482631000&id=215693965130780","citation_ids":[1262288],"posted_on":"2013-02-28T13:35:51+00:00","summary":"PubMed comprises more than 22 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.","author":{"name":"Hotel Melanoma","url":"https:\/\/www.facebook.com\/215693965130780","facebook_wall_name":"Hotel Melanoma","image":"https:\/\/graph.facebook.com\/215693965130780\/picture","id_on_source":"215693965130780"}}]}}